Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LFWD Stock Forecast 2025-2026
$1.29
Current Price
$13.71M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to LFWD Price Targets
+907.8%
To High Target of $13.00
+675.2%
To Median Target of $10.00
+132.6%
To Low Target of $3.00
LFWD Price Momentum
-5.8%
1 Week Change
-7.2%
1 Month Change
-74.5%
1 Year Change
-25.4%
Year-to-Date Change
-75.4%
From 52W High of $5.25
+5.7%
From 52W Low of $1.22
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching ReWalk (LFWD) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on LFWD and similar high-potential opportunities.
Latest LFWD Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, LFWD has a bullish consensus with a median price target of $10.00 (ranging from $3.00 to $13.00). Currently trading at $1.29, the median forecast implies a 675.2% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Swayampakula Ramakanth at HC Wainwright & Co., projecting a 907.8% upside. Conversely, the most conservative target is provided by Swayampakula Ramakanth at HC Wainwright & Co., suggesting a 132.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LFWD Analyst Ratings
3
Buy
0
Hold
0
Sell
LFWD Price Target Range
Low
$3.00
Average
$10.00
High
$13.00
Current: $1.29
Latest LFWD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LFWD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 11, 2025 | Lake Street | Ben Haynor | Buy | Maintains | $4.00 |
| Mar 11, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
| Feb 20, 2025 | Lake Street | Ben Haynor | Buy | Maintains | $4.50 |
| Feb 20, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
| Feb 10, 2025 | Laidlaw & Co. | Yale Jen | Buy | Initiates | $10.00 |
| Nov 13, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
| Aug 16, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $13.00 |
| May 16, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $13.00 |
| Apr 15, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $9.00 |
| Feb 28, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.00 |
| Nov 15, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
| Aug 14, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
| Aug 10, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
| Jul 3, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
| May 12, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
| Feb 24, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
| Nov 15, 2022 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
| Aug 10, 2022 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
| Mar 1, 2021 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
| Aug 13, 2020 | HC Wainwright & Co. | Buy | Maintains | $0.00 |
Lifeward Ltd. (LFWD) Competitors
The following stocks are similar to ReWalk based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
LFWD
ReWalk Robotics
mkt cap
14.56M
Lifeward Ltd. (LFWD) Financial Data
Lifeward Ltd. has a market capitalization of $13.71M with a P/E ratio of -0.4x. The company generates $25.66M in trailing twelve-month revenue with a -112.8% profit margin.
Revenue growth is +9.6% quarter-over-quarter, while maintaining an operating margin of -80.0% and return on equity of -88.6%.
Valuation Metrics
Market Cap
$13.71M
Enterprise Value
$9.44M
P/E Ratio
-0.4x
PEG Ratio
-1.4x
Price/Sales
0.5x
Growth & Margins
Revenue Growth (YoY)
+9.6%
Gross Margin
+24.4%
Operating Margin
-80.0%
Net Margin
-112.8%
EPS Growth
+9.6%
Financial Health
Cash/Price Ratio
+49.2%
Current Ratio
2.1x
Debt/Equity
4.7x
ROE
-88.6%
ROA
-26.9%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Lifeward Ltd. (LFWD) Business Model
About Lifeward Ltd.
What They Do
Healthcare solutions provider focusing on medical devices.
Business Model
Lifeward Ltd. generates revenue by developing, producing, and distributing innovative medical devices and health management systems. The company serves various sectors, including hospitals, clinics, and home healthcare, which allows it to diversify its product offerings and client base, enhancing its market reach and profitability.
Additional Information
Lifeward Ltd. plays a critical role in advancing patient monitoring and management technologies. Its focus on integrating cutting-edge technology into healthcare practices positions it strategically in the evolving healthcare market, ensuring that it meets the growing demand for efficient and effective patient care solutions.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
80
CEO
Mr. Lawrence J. Jasinski BS, MBA
Country
Israel
IPO Year
2014
Website
golifeward.comLifeward Ltd. (LFWD) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Lifeward (LFWD) delivered earnings and revenue surprises of -39.39% and 16.24%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
May 15, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Lifeward Ltd. (NASDAQ: LFWD) will hold its Q1 2025 earnings conference call on May 15, 2025, at 8:30 AM ET, featuring CFO Mike Lawless and CEO Larry Jasinski.
Why It Matters
Lifeward Ltd.'s upcoming earnings call will provide insights into its financial performance and strategic direction, potentially impacting stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
ReWalk has over 120 qualified leads in its pipeline. AlterG's site closures have improved operating expenses, contributing to a 15% revenue growth for the second consecutive quarter.
Why It Matters
The growth in ReWalk opportunities and AlterG's revenue signals strong potential for Lifeward's market expansion and improved financial health, positively impacting investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Lifeward (LFWD) reported a quarterly loss of $0.46 per share, exceeding the estimated loss of $0.33, but an improvement from a $0.73 loss per share a year ago.
Why It Matters
Lifeward's larger-than-expected loss signals ongoing financial struggles, potentially affecting investor confidence and stock performance. Year-over-year improvement may offer some optimism.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Lifeward Ltd. has announced news affecting its operations in Marlborough, Massachusetts, and Yokneam Illit, Israel, on May 8, 2025. Further details were not provided.
Why It Matters
Lifeward Ltd.'s announcement may indicate new developments or partnerships, potentially impacting stock performance and market confidence in related sectors.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Lifeward Ltd. (Nasdaq: LFWD) will release its Q1 2025 financial results on May 15, 2025, before market opening.
Why It Matters
Lifeward's upcoming Q1 2025 financial results could impact stock performance, indicating growth or challenges in the medical tech sector, influencing investor sentiment and decisions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
17 days ago
Quick Summary
Major U.S. commercial health insurers are beginning to cover personal exoskeletons, following Medicare's 2024 precedent. This follows the launch of the ReWalk 7 exoskeleton in April 2025.
Why It Matters
The approval for Medicare reimbursement of personal exoskeletons indicates a significant market expansion opportunity, potentially boosting sales for companies like Lifeward Ltd. and attracting investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About LFWD Stock
What is Lifeward Ltd.'s (LFWD) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, Lifeward Ltd. (LFWD) has a median price target of $10.00. The highest price target is $13.00 and the lowest is $3.00.
Is LFWD stock a good investment in 2025?
According to current analyst ratings, LFWD has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.29. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LFWD stock?
Wall Street analysts predict LFWD stock could reach $10.00 in the next 12 months. This represents a 675.2% increase from the current price of $1.29. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Lifeward Ltd.'s business model?
Lifeward Ltd. generates revenue by developing, producing, and distributing innovative medical devices and health management systems. The company serves various sectors, including hospitals, clinics, and home healthcare, which allows it to diversify its product offerings and client base, enhancing its market reach and profitability.
What is the highest forecasted price for LFWD Lifeward Ltd.?
The highest price target for LFWD is $13.00 from Swayampakula Ramakanth at HC Wainwright & Co., which represents a 907.8% increase from the current price of $1.29.
What is the lowest forecasted price for LFWD Lifeward Ltd.?
The lowest price target for LFWD is $3.00 from Swayampakula Ramakanth at HC Wainwright & Co., which represents a 132.6% increase from the current price of $1.29.
What is the overall LFWD consensus from analysts for Lifeward Ltd.?
The overall analyst consensus for LFWD is bullish. Out of 4 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $10.00.
How accurate are LFWD stock price projections?
Stock price projections, including those for Lifeward Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 16, 2025 5:11 PM UTC